Zobrazeno 1 - 4
of 4
pro vyhledávání: '"W E, Hoogendoorn"'
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 149(40)
To examine the viability of tracing new patients with a malignancy preoperatively through the Nationwide Network And Registry Of Histo- and Cytopathology in the Netherlands (PALGA) in order to obtain fresh-frozen tumour tissue for molecular-epidemiol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::89115af9ab5d5e591f263996c69bca0b
https://pubmed.ncbi.nlm.nih.gov/16235800
https://pubmed.ncbi.nlm.nih.gov/16235800
Autor:
M A, Jonker, C E, Jacobi, W E, Hoogendoorn, N J D, Nagelkerke, Geertruida H, de Bock, Johannes C, van Houwelingen
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 12(12)
The purpose of this research was to model the familial clustering of breast cancer and to provide an accurate risk estimate for individuals from the general population, based on their family history of breast and ovarian cancer. We constructed a gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e5b9bcbe52e6eff7897145784de650b2
https://pubmed.ncbi.nlm.nih.gov/14693741
https://pubmed.ncbi.nlm.nih.gov/14693741
Publikováno v:
Journal of Medical Genetics, 40. BMJ Publishing Group
Jonker, M A, de Bock, G H, Hoogendoorn, W E, van Asperen, C J & Houwelingen, J C 2003, ' Little value from including cousins in individual risk assessment of hereditary breast cancer. A simulation study. ', Journal of Medical Genetics, vol. 40, pp. e25 . https://doi.org/10.1136/jmg.40.3.e25
Jonker, M A, de Bock, G H, Hoogendoorn, W E, van Asperen, C J & Houwelingen, J C 2003, ' Little value from including cousins in individual risk assessment of hereditary breast cancer. A simulation study. ', Journal of Medical Genetics, vol. 40, pp. e25 . https://doi.org/10.1136/jmg.40.3.e25
Breast cancer is a common disease in women. The lifetime risk of breast cancer is about 1 in 12 in the UK, 1 in 10 in The Netherlands, and 1 in 8 in the USA.1 The majority of women are affected in the peri- or postmenopausal years: about 75% of all b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::618417b5432196237127eb091903fdda
https://pubmed.ncbi.nlm.nih.gov/12624154
https://pubmed.ncbi.nlm.nih.gov/12624154
Possible consequences of applying guidelines to healthy women with a family history of breast cancer
Autor:
R.A.E.M. Tollenaar, Jan G. M. Klijn, C. J. van Asperen, Cees J. Cornelisse, Caroline M. Seynaeve, Cecile T. M. Brekelmans, E M M Krol-Warmerdam, W E Hoogendoorn, J. Blom, G. H. de Bock, Peter Devilee
Publikováno v:
European Journal of Human Genetics, 11, 633-636. Nature Publishing Group
European Journal of Human Genetics, 11(8), 633-636. Nature Publishing Group
European Journal of Human Genetics, 11(8), 633-636. Nature Publishing Group
Possible effects of consistently applying published guidelines on healthy women with breast cancer in their family history were analysed. We investigated 1060 unrelated breast cancer patients and calculated the numbers of first-degree relatives that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e14fda1441a0db2d88ab28cdc3287322
https://pure.eur.nl/en/publications/0ba7b94c-4854-47d3-9bb9-34932d375d0f
https://pure.eur.nl/en/publications/0ba7b94c-4854-47d3-9bb9-34932d375d0f
